CARRIE FORHETZ: Open Payments
NPI 1376203703 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 15 payments from 11 companies in 2025. Trend: 2023 $1,205 · 2024 $1,867 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $56 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: Wegovy, ELIQUIS, OTEZLA, SHINGRIX, Kerendia, QULIPTA, CAPLYTA, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
